Venebio Opioid Advisor

Background

Venebio Opioid Advisor uses multiple demographic and clinical variables that are automatically identified and retrieved from the patient’s electronic medical records or other sources. The algorithm uses proprietary logic to create a personalized risk profile for each patient and compares it to reference data gleaned from tens of millions of patients who have previously been treated with opioids. Venebio Opioid Advisor then calculates each patient’s risk score and predicted probability of experiencing OIRD during the next six months. Venebio Opioid Advisor can integrate directly with electronic medical records, or with other systems such as an analytics warehouse, population health platform, or health information exchange (HIE). Further, the tool can be reliably and accurately operated by trained non-physician healthcare professionals (e.g., PA, RN, LPN), saving valuable time for other clinicians.

Venebio Opioid Advisor 02920 Pain management narcotics drug abuse overdose drug seeking behavior patient safety Venebio Group
Evidence: 
  1. Zedler B., L. Xie, L. Wang, A. Joyce, C. Vick, F. Kariburyo, P. Rajan, O. Baser, and L. Murrelle. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Medicine, 2014. 15(11): p. 1911-29.
  2. Zedler B., L. Xie, L. Wang, A. Joyce, C. Vick, J. Brigham, F. Kariburyo, O. Baser, and L. Murrelle. Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans’ Health Administration patients. Pain Medicine, 2015. 16(8): p. 1566-79.
  3. Zedler B., W. Saunders, A. Joyce, C. Vick, and E. Murrelle. Validation of a screening risk index for prescription opioid overdose or serious opioid-related respiratory depression in a U.S. commercial health plan claims database. Forthcoming in Pain Medicine, 2017.
  4. Nadpara P., A. Joyce, L. Murrelle, N.C. Carroll, N.V. Carroll, M. Barnard, B. Zedler. Risk factors for serious prescription opioid-induced respiratory depression or overdose: comparison of commercially insured and Veterans Health Affairs populations. Forthcoming in Pain Medicine, 2017.
  5. Weiner S.G., A. Joyce, H. Thomson. The prevalence of nasal obstruction as a consideration in the treatment of opioid overdose. Forthcoming in Journal of Opioid Management, 2017.
CID: 
02920